We are live on ! Find out more
TPTX

Turning Point Therapeutics, Inc. Common Stock
TPTX

Delisted

TPTX was delisted on the 16th of August, 2022.

Back to rankings

98 hedge funds and large institutions have $900M invested in Turning Point Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 35 increasing their positions, 8 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

338% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 8

233% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 12

67% more funds holding in top 10

Funds holding in top 10: 3 → 5 (+2)

40% more funds holding

Funds holding: 70 → 98 (+28)

21% more capital invested

Capital invested by funds: $742M → $900M (+$158M)

Holders
98
Holders Change
+28
Holders Change %
+40%
% of All Funds
2.15%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.11%
New
40
Increased
35
Reduced
8
Closed
12
Calls
$425K
Puts
–
Net Calls
+$425K
Net Calls Change
+$425K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$27.1M
2
Wells Fargo
Wells Fargo
California
+$23.1M
3
CAM
Cormorant Asset Management
Massachusetts
+$18.2M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$14.1M
5
American Century Companies
American Century Companies
Missouri
+$13.7M

Top Sellers

Rank Fund Capital Flow
1
PC
Polar Capital
United Kingdom
-$9.14M
2
LCM
Laurion Capital Management
New York
-$3.05M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.91M
4
Citadel Advisors
Citadel Advisors
Florida
-$1.85M
5
MWNA
Marshall Wace North America
New York
-$1.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
Rafferty Asset Management
51
Rafferty Asset Management
New York
$947K +$1.1M +25,181 New
AC
52
Athanor Capital
New York
$895K +$461K +10,600 +80%
TD Asset Management
53
TD Asset Management
Ontario, Canada
$875K +$1.01M +23,279 New
PPA
54
Parametric Portfolio Associates
Washington
$837K +$969K +22,253 New
Prudential Financial
55
Prudential Financial
New Jersey
$784K +$908K +20,860 New
N
56
Nuveen
North Carolina
$624K – – –
Ameriprise
57
Ameriprise
Minnesota
$587K -$1.05M -24,125 -61%
KCM
58
Kennedy Capital Management
Missouri
$580K +$671K +15,422 New
PCM
59
Pentwater Capital Management
Florida
$564K +$653K +15,000 New
Citigroup
60
Citigroup
New York
$531K +$535K +12,283 +663%
Squarepoint
61
Squarepoint
New York
$493K +$571K +13,112 New
WCM
62
Weld Capital Management
New York
$486K +$563K +12,923 New
QI
63
QS Investors
New York
$476K – – –
New York State Common Retirement Fund
64
New York State Common Retirement Fund
New York
$462K – – –
OAM
65
Oxford Asset Management
United Kingdom
$405K +$469K +10,779 New
AR
66
Advisory Research
Illinois
$395K +$457K +10,498 New
California State Teachers Retirement System (CalSTRS)
67
California State Teachers Retirement System (CalSTRS)
California
$384K – – –
DTL
68
Dynamic Technology Lab
Singapore
$378K +$438K +10,053 New
MCM
69
Moore Capital Management
New York
$376K +$435K +10,000 New
State of Wisconsin Investment Board
70
State of Wisconsin Investment Board
Wisconsin
$376K +$435K +10,000 New
SEI Investments
71
SEI Investments
Pennsylvania
$346K +$400K +9,199 New
Bank of America
72
Bank of America
North Carolina
$339K +$275K +6,315 +233%
Morgan Stanley
73
Morgan Stanley
New York
$314K +$358K +8,221 +7,149%
RhumbLine Advisers
74
RhumbLine Advisers
Massachusetts
$253K +$39.7K +911 +16%
HighTower Advisors
75
HighTower Advisors
Illinois
$220K – – –
1 2
3
4 5

TPTX Hedge Fund Activity: Q3 2019 in Review

98 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Turning Point Therapeutics, Inc. Common Stock (TPTX) for Q3 2019, worth a combined $900M — up 21% from $742M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new TPTX positions and 12 closed out — a net gain of 28 holders — while 35 added to existing stakes and 8 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $27.1M. The largest seller was Polar Capital, exiting entirely with an estimated $9.14M sold.

  • 98 institutional investors held Turning Point Therapeutics, Inc. Common Stock (TPTX) as of Q3 2019, up from 70 in Q2 2019.
  • Funds reported $900M of Turning Point Therapeutics, Inc. Common Stock stock for Q3 2019, up 21% quarter-over-quarter.
  • 40 funds opened new Turning Point Therapeutics, Inc. Common Stock positions in Q3 2019 and 12 closed out, a net change of +28 holders.
  • The largest Turning Point Therapeutics, Inc. Common Stock buyer in Q3 2019 was Fidelity Investments, an estimated $27.1M added.
  • The largest Turning Point Therapeutics, Inc. Common Stock seller in Q3 2019 was Polar Capital, an estimated $9.14M sold.

Based on aggregated 13F filings for Q3 2019.